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RFLPSleep disturbance is common in several epilepsy types, such as juvenile myoclonic epilepsy (JME). Genetic back-
ground could increase susceptibility to seizure and sleep abnormalities. From this perspective, a susceptibility
gene for sleep disturbance or chronotype could contribute to the genetic susceptibility threshold for epilepsy
and vice versa. Accordingly, we investigated whether functional clock gene polymorphisms (PER2 111CNG,
CLOCK 3111TNC, and PER3 VNTR) might inﬂuence the risk for JME. All these polymorphisms have recently
been reported to be associatedwith sleep disturbance, diurnal variation, and neurological diseases. The polymor-
phisms were genotyped in 97 patients and 212 controls using polymerase chain reaction or restriction fragment
length polymorphismmethods. No signiﬁcant differenceswere observed in the genotypic and allelic frequencies
of these polymorphismsbetween cases and controls evenwhen analyseswere restricted to patients that present-
ed a diurnal preferential seizure occurrence.We also tested for interactions between polymorphisms bymultifac-
tor dimensionality reduction analysis. None of the combined genotypes differed signiﬁcantly between the
groups. These results present no evidence for an association of these polymorphisms with JME. Further studies
including other types of epilepsy and/or other functional polymorphisms are required to investigate the possible
relationship between clock genes and the genetic susceptibility to chronic seizure.
© 2014 Elsevier Inc. All rights reserved.1. Introduction
Juvenile myoclonic epilepsy (JME) is a subtype of common genetic
generalized epilepsy with an estimated prevalence of 0.1–2 per
100000 population and accounts for 10% of all forms of epilepsy [1–3].
Onset is at puberty with equal sex ratio, and it is characterized by myo-
clonic seizures, occasional generalized tonic–clonic seizures, and, some-
times, absence seizures [4]. The occurrence of myoclonic jerks early in
the morning is one of the hallmarks of JME [5]. It is also highly drug-
responsive since a frequent recurrence is reported after AED discontinu-
ation [6]. The genetics of JME are complex and probably involves the in-
teraction of multiple genes with minor effect and environmental factors
[7]. In order to identify susceptibility genes for JME, an experimental ap-
proachdirected to candidate genes selected according to theirmolecular
function has been widely used in genetic association studies [8].+55 82 3221 2501.
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. Gitaí).Juvenile myoclonic epilepsy has a complex relationship with sleep,
the latter affecting the former and vice versa. In fact, patients with JME
have signiﬁcant sleep disturbances characterized by excessive daytime
sleepiness and disturbed night sleep, despite adequate medications
and good seizure control [9,10]. It was also observed that JME might
contribute to the poor quality of sleep and that epileptiform activity
occurs more often in sleep than wakefulness [11]. In JME, occurrence
of seizures and epileptiform EEG discharges is inﬂuenced strongly
by sleep deprivation [5,12,13]. Moreover, signiﬁcant differences in
morningness/eveningness distribution, timing of midsleep, and total
sleep time were found between patients with epilepsy and healthy
controls [14].
Accumulating evidence indicates that clock genes regulate the
sleep–wake cycle and circadian preference. Several clock genes, includ-
ing PER1, PER2, PER3, CRY1, CRY2, BMAL1, CLOCK, and casein kinase 1
delta/epsilon (CK1D and CK1E), interact in translational–transcriptional
autoregulatory feedback loops to generate circadian rhythms [15].
Among these genes, CLOCK, PER2, and PER3 are of particular interest
since they contain functional polymorphisms which have recently
been reported to be associated with sleep disturbance and diurnal
preference [16–27].
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the ﬁrst to be reported affecting diurnal preference [16]. The genotype
CLOCK rs1801260*CC was associated with evening preference, delayed
sleep onset, and was characterized by shorter sleep time in comparison
to the subjectswith CLOCK rs1801260*T allele [17,18]. Themost studied
PER2 variant is rs2304672, located at the 5′-UTR region, which has been
associated with extreme morning preference [19] and advanced sleep
phase syndrome (ASPS) [20]. Finally, PER3 contains a VNTR polymor-
phism (rs57875989) in the coding region, based on 4-repeat or 5-
repeat alleles, which has been reported to be associated with delayed
sleep phase syndrome [21,22] and homeostatic sleep drive in healthy
individuals [23–27].
Furthermore, these genetic variations were consistently involved in
the susceptibility to several neurological and chronic diseases, such as
bipolar disorder [28,29], schizophrenia [30,31], and attention deﬁcit
hyperactivity disorder (ADHD) [32–34]. However, there are no reported
studies that investigated if these or other variants of clock genes are
associated with epilepsy, despite the fact that some of these genes pre-
sented an expression proﬁle changed during the epileptogenic process
in an animal model [35].
We performed this case/control study to evaluate whether the PER2
rs2304672, CLOCK rs1801260 and PER3 rs57875989 polymorphisms
might inﬂuence the risk for JME. In addition, a possible interaction
among the three polymorphisms was investigated.
2. Materials and methods
2.1. Patients
This study included 309 individuals composed of 97 unrelated
patients with JME and 212 healthy control subjects, all of whom were
recruited from the state of Alagoas in northeastern Brazil. The study
was approved by the Ethics Committee of the Federal University of
Alagoas, Brazil (no. 004660/2011-71). Cases were matched with con-
trols according to age, sex, and geographic location of origin. Individuals
with a history of epileptic seizures or neuropsychiatric disorders were
excluded from the control sample. The probands were unambiguously
diagnosed cases of JME with classiﬁcation based on the published
criteria of the Commission on Classiﬁcation and Terminology of the
International League Against Epilepsy (ILAE) [36]. All patients were
submitted to electroencephalography analysis, and only those with
generalized spike wave were included in this study.
2.2. Genotyping
Using the FlexiGeneDNAKit (Qiagen, USA), DNAwas extracted from
peripheral blood leucocytes. Genotyping for rs1801260 and rs57875989
was performed as previously described in [21,37], respectively. For
rs2304672 in PER2 gene, a total of 50 ng of genomic DNA was mixed
with 5 pmol of each PCR primer in a total volume of 25 μL containing
1× PCR buffer (200mMTris–HCl pH 8.4, 500mMKCl), 1.5 mMmagne-
sium chloride, 0.2 mM of each deoxyribonucleotide triphosphate, and
0.5 U of DNA polymerase (Invitrogen, Carlsbad, CA). The primers 5′-
GTGCGTGTGCTTGTTAATGC-3′ (forward) and 5′-TCCTTGGTGGGGTTAC
TGG-3′ (reverse) were used to obtain PCR products of 114 bp size
(GenBank accession no. ref. | NG_012146.1). The reaction mixture was
cycled as follows in a DNA thermal cycler (BioCycler, MJ96G model):
Denaturation at 94 °C for 3 min was followed by 35 cycles at 94 °C for
45 s, 55 °C for 45 s, and 72 °C for 45 s, and a ﬁnal extension at 72 °C
for 7 min. A 20 μL aliquot of the PCR product was then submitted to
restriction reaction at 37 °C for 16 h with HpyCH4V restriction enzyme
(Fermentas Life Sciences, USA). Fragments were separated by electro-
phoresis on 8% polyacrylamide gels and were visualized by ultraviolet
light after staining with ethidium bromide. One uncut fragment of
114 bp is observed in the case of the rs2304672*CC genotype, whereas
in the heterozygous samples, three fragments of 114 bp, 61 bp, and53 pb can be observed. In the presence of the rs2304672*GG genotype,
two fragments of 61 pb and 53 pb are observed.
2.3. Statistical analysis
All descriptive and statistical analyses for comparing clinical infor-
mation between case and control groups and association with single
variants were performed using SNPstats, a web-based tool offered by
the Biostatistics and Bioinformatics Unit Web of The Catalan Institute
of Oncology [38]. The following parameters were analyzed: Allele and
genotype frequencies, Hardy–Weinberg disequilibrium, and SNP associ-
ation with a response variable and odds ratio (OR) together with the
95% conﬁdence interval (95% CI). We then estimated the OR adjusted
for the clinical variables that were selected in the general linear model
analysis with a logistic regression stepwise procedure. The selected
variables evaluatedwere sex, pharmacological treatment, type of seizure,
and genotype.
The statistical power of the sample for detecting association was
performed by the G*Power v3.1.3 software [39] using the following
parameters: logistic regression test, two-tail analysis, size sample =
309, minimum odds ratio (OR) = 1.5, and statistical signiﬁcance level
α = 0.05. In addition, multifactor dimensionality reduction (MDR)
analysis was used in order to evaluate SNP–SNP interaction, using the
MDR software [40]. Hypothesis testing and multiple comparisons
adjustment were performed using the permutation approach of the
MDR Permutation Test (beta 0.4.5) software, which generates empirical
null distribution of prediction accuracy and compares it with the value
of the ﬁnal best model. We evaluated from one to four SNP combina-
tions in our MDR analysis and used 10000 permutations for hypothesis
testing. Signiﬁcance was considered at both the 5% and 10% level for
multivariate and MDR analysis.
3. Results
Demographic and clinical data of the unrelated patients with JME
were reported previously [41]. Table 1 shows both allelic and genotypic
frequencies of the studied polymorphisms in the two groups under
study. The genotype distribution did not show Hardy–Weinberg dis-
equilibrium as estimated by the chi-square test. Duplicated genotyping
of 30% of the samples revealed 100% of concordance. Genotype and
allele frequencies for the three polymorphisms studied did not differ
signiﬁcantly between the groups (Table 1) even when the OR was
adjusted for the clinical variables (data not shown). We found that the
study had a power of 80.25% to detect an association in our sample for
a nominal signiﬁcance level α of 0.05.
In order to investigate a possible association in a restricted sample,
we performed the genetic association analysis using just patients with
JME that presented a diurnal preferential seizure occurrence and com-
paring them with control individuals. No differences were found
between the groups (data not shown).
We also tested for interactions between polymorphisms comparing
the patients with the control individuals. With the MDR analysis, we
found that the best model for the interaction between rs1801260
(CLOCK) and rs57875989 (PER3) showed a testing balanced accuracy
of 0.5614 and a cross-validation consistency of 10/10 (Table 2). None
of the combined genotypes differed signiﬁcantly between the groups
(Table 2).
4. Discussion and conclusion
A susceptibility gene for sleep disturbance could contribute to the
genetic susceptibility threshold for epilepsy and vice versa. In fact,
mutations in the voltage-gated sodium channel (VGSC) gene SCN1A,
for example, are responsible for both epilepsy disorders and sleep
abnormalities, and recently, it was suggested that there is a common
pathway for the clinical features (seizures and sleep abnormalities)
Table 1
Comparative analysis between genotypic frequencies obtained in groups of patients with epilepsy and controls (n = 309 without adjustment for gender).
rs2304672 polymorphism in PER2 gene
Genotype Controls Patients OR (95% CI) p-Valuea AIC BIC
C/C 184 (86.8%) 86 (88.7%) 1.00
C/G 28 (13.2%) 11 (11.3%) 0.84 (0.40–1.77) .64 388.3 395.8
rs1801260 polymorphism in CLOCK gene
Model Genotype Controls Patients OR (95% CI) p-Valuea AIC BIC
Codominant T/T 138 (65.1%) 54 (55.7%) 1.00
T/C 64 (30.2%) 37 (38.1%) 1.48 (0.88–2.47) .29 388 399.2
C/C 10 (4.7%) 6 (6.2%) 1.53 (0.53–4.43)
Dominant T/T 138 (65.1%) 54 (55.7%) 1.00
T/C–C/C 74 (34.9%) 43 (44.3%) 1.48 (0.91–2.42) .11 386 393.5
Recessive T/T–T/C 202 (95.3%) 91 (93.8%) 1.00
C/C 10 (4.7%) 6 (6.2%) 1.33 (0.47–3.78) .59 388.2 395.7
Overdominant T/T–C/C 148 (69.8%) 60 (61.9%) 1.00
T/C 58 (30.2%) 37 (38.1%) 1.43 (0.86–2.36) .17 386.6 394.1
Log-additive – – – 1.36 (0.91–2.02) .14 386.3 393.8
rs57875989 VNTR in PER3 gene
Model Genotype Controls Patients OR (95% CI) p-Valuea AIC BIC
Codominant 4/4 95 (44.8%) 42 (43.3%) 1.00
4/5 92 (43.4%) 43 (44.3%) 1.06 (0.63–1.77) .97 390.5 401.7
5/5 25 (11.8%) 12 (12.4%) 1.09 (0.50–2.36)
Dominant 4/4 95 (44.8%) 42 (43.3%) 1.00 .80 388.5 395.9
4/5–5/5 117 (55.2%) 55 (56.7%) 1.06 (0.66–1.73)
Recessive 4/4–4/5 187 (88.2%) 85 (87.6%) 1.00 .88 388.5 396
5/5 25 (11.8%) 12 (12.4%) 1.06 (0.51–2.20)
Overdominant 4/4–5/5 120 (56.6%) 54 (55.7%) 1.00 .88 388.5 396
4/5 92 (43.4%) 43 (44.3%) 1.04 (0.64–1.69)
Log-additive – – – 1.05 (0.73–1.49) .80 388.5 395.9
OR (odds ratio); AIC (Akaike information criterion); BIC (Bayesian information criterion).
a Logistic regression.
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whether the PER2 rs2304672, CLOCK rs1801260, and PER3
rs57875989 polymorphisms could inﬂuence the risk for JME. All these
polymorphisms have recently been reported to be associated with
sleep disturbance and diurnal variation. However, to the best of our
knowledge, this is the ﬁrst study investigating a possible association
of polymorphisms in clock genes with epilepsy.
Our study included only the patients with JME rather than analyzing
a clinically heterogeneous population with several epilepsy syndromes.
This approach might have minimized possible bias from the limited
sample size, which is a common problem in genetic association studies.
We did not observe a signiﬁcant difference in genotypic or allelic
frequencies for these polymorphisms between the patients with JME
and controls even when OR was adjusted for sex and/or ethnicity.
Considering that each polymorphism may be only a weak contributor
and the individual effects of each of these polymorphisms could not
be observed, we also performed a genetic interaction analysis. For this,
we utilized the recently developedMDR and interaction entropy strategy
to access and interpret potential interaction among these genes. None of
the combined genotypes differed signiﬁcantly between the groups
(Table 2).Table 2
MDR analysis for polymorphisms.
Model Training balance
accuracy
Testing balance
accuracy
CVC p-Valuea
P1 ∗ P2 0.5549 0.5614 10/10 .6751
P1 ∗ P2 ∗ P3 0.5082 0.4976 10/10 .7560
P1 (rs1801260, 3111TNC of CLOCK gene); P2 (rs57875989, VNTR 4–5 repetitions of PER3
gene); P3 (rs2304672, 111CNG of PER2 gene); CVC = cross-validation consistency.
a Obtained p-value of 10000 permutation tests.Heterogeneity represents the single biggest contributor to
phenotype-related problems in genetic analysis of any commondisease
[43]. Restricting the dimension of a phenotype is a relevant way tomax-
imize the chances of detecting epilepsy genetic risk factors. Then, we
performed the genetic association analysis using just the patients with
JME that presented a diurnal preferential seizure occurrence and com-
pared them with the control individuals. Also, the allelic and genotypic
frequencies for the three polymorphisms were not different between
the groups.
These data suggest that the investigated PER2, CLOCK, and PER3
polymorphisms are not related to JME susceptibility, at least in this
Brazilian sample. However, proof that association indeed does not
exist would need replication of our ﬁndings in independent samples.
Moreover, further studies including other types of epilepsy and/or
other functional polymorphisms are required to investigate the
relationship between clock genes and genetic susceptibility to chronic
seizures.
Our data also contribute to the investigation of the frequency of
PER2, CLOCK, and PER3 polymorphisms in the Brazilian population.
Taking into account the general population, including both patient and
control individuals, the allele frequencies of the polymorphisms
observed in this study are the following: C (94%) and G (6%) for
rs2304672, 4 repeats (66%) and 5 repeats (34%) for rs57875989, and T
(78%) and C (22%) for rs1801260. These data are consistent with those
observed in other worldwide subpopulations, suggesting that ethnic
differences did not interfere in the distribution of these genetic variants
[16,17,30,37,44–47].Conﬂict of interest statement
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